找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Resistant Hypertension; Massimo Salvetti Book 2016 Springer International Publishing Switzerland 2016 Difficult-to-treat hypertension.Fals

[復(fù)制鏈接]
樓主: 懇求
11#
發(fā)表于 2025-3-23 10:43:41 | 只看該作者
12#
發(fā)表于 2025-3-23 14:05:25 | 只看該作者
13#
發(fā)表于 2025-3-23 21:32:03 | 只看該作者
14#
發(fā)表于 2025-3-24 00:55:19 | 只看該作者
Adult Patient with Pseudo-Resistant Hypertension: Spurious Resistant Hypertension,ue resistance to treatment. In fact, studies have shown that up to one third of patients with suspected resistant hypertension have normal 24-h (or home) blood pressure values and that these patients have much less organ damage and a better prognosis as compared to “true resistant” hypertensives.
15#
發(fā)表于 2025-3-24 05:02:44 | 只看該作者
16#
發(fā)表于 2025-3-24 10:21:20 | 只看該作者
Adult Patient with Pseudo-Resistant Hypertension: High Blood Pressure Induced by Exogenous Substancfactors responsible for poor BP control. In these patients, after the assessment of adherence to lifestyle measures and to drug treatment, the diagnostic workup should include the evaluation of possible secondary forms of hypertension. An accurate evaluation of the drugs and substances assumed by th
17#
發(fā)表于 2025-3-24 12:51:17 | 只看該作者
18#
發(fā)表于 2025-3-24 16:35:13 | 只看該作者
Adult Patient with Pseudo-Resistant Hypertension: Drug Intolerance,ved. Today, several classes of effective antihypertensive drugs are available, and in particular ACE inhibitors, angiotensin II receptor blockers, calcium antagonists, diuretics and beta blockers are all considered first-line drugs by current European Guidelines; furthermore, other molecules may be
19#
發(fā)表于 2025-3-24 21:38:02 | 只看該作者
20#
發(fā)表于 2025-3-25 02:12:33 | 只看該作者
Adult Patient with Resistant Hypertension Secondary to Comorbidities,ic. Lifestyle was certainly not optimal in this obese patient. Obesity and overweight are quite common in patients with BP elevation, being present in about 75?% of the hypertensive patients seen by general practitioners or specialists. Together with combination treatment with antihypertensive drugs
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 21:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
阳高县| 香河县| 巴林右旗| 南充市| 尤溪县| 桐庐县| 叙永县| 南丰县| 绥宁县| 鲁甸县| 吉首市| 曲靖市| 尼玛县| 云阳县| 雷州市| 镇赉县| 甘孜| 绥化市| 奉新县| 桐城市| 扬州市| 若羌县| 松潘县| 海伦市| 洛宁县| 定结县| 琼中| 兴国县| 临潭县| 左权县| 罗田县| 合水县| 海盐县| 武宣县| 乃东县| 思南县| 仁布县| 昭觉县| 宁远县| 宁明县| 鹿邑县|